CDK1 and neoplasm: MiR-21 promotes tumor cell proliferation by inhibiting PDCD4 (programmed cell death protein 4), a tumor suppressor that prevents cell cycle progression via activation of the cyclin-dependent kinase 1 (Cdk1) inhibitor p21 [70].